Industry Symposia

Industry Symposia Program

Discover the industry sessions that took place at WCN on Sunday, April 14 and Monday, April 15. These 13 sessions, delivered the latest advancements in global kidney care, and were scheduled at either 8:30a.m. or 1:45p.m. Selected sessions were live streamed. All symposia are now available on-demand on the ISN Academy with open-access.

  • Navigating Newer Approaches to Managing IgA Nephropathy
  • Organized by Physicians’ Education Resources, supported by Travere Therapeutics
  • 13:45 – 14:45 | Hall C1

  • Caring for the kidney to protect the heart: hitting two birds with one stone
  • Organized by Bayer AG
  • 13:45 – 14:45 | Hall C2

  • Emerging Concepts on Chronic Kidney Disease: From Nephroprotection to Hyperkalemia
  • Organized by AstraZeneca
  • 13:45 – 14:45 | Hall C3

  • IgA Nephropathy and APRIL: From bench to the clinical world
  • Scientific content by ISN, supported by Otsuka, Visterra
  • 13:45 – 14:45 | Hall C4
  • Complement in C3G and IC-MPGN: where do we stand and what does the future hold?
  • Organized by Novartis
  • 13:45 – 14:45 | Hall D
  • Comprehensive Approaches to Chronic Kidney Disease: Improving Diagnosis and Patient Management
  • Organized by Med Learning Group, supported by Boehringer Ingelheim & Lilly
  • 13:45 – 14:45 | Hall E

  • Evolving care for people with CKD: the role of SGLT2 inhibitors
  • Organized by Boehringer Ingelheim & Lilly
  • 8:30 – 9:00 | Hall C2

  • Evolving Landscape of eGFR and Proteinuria Surrogate Markers in IgA Nephropathy
  • Organized by Calliditas Therapeutics
  • 13:45 – 14:45 | Hall C1

  • Clinical and Real-World Evidence: Immediate, Complete and Sustained C5 Inhibition in aHUS
  • Organized by Alexion AstraZeneca Rare Disease
  • 13:45 – 14:45 | Hall C2

  • GLP1 RA: Setting a new chapter in T2D & CKD
  • Organized by Novo Nordisk
  • 13:45 – 14:45 | Hall C3

  • Targeting the Source of IgA Nephropathy: Focus on BAFF and APRIL Pathways.
  • Organized by Vera Therapeutics
  • 13:45 – 14:45 | Hall C4

  • Managing Patients with IgA Nephropathy: Taking it to the Next Level
  • Organized by Novartis
  • 13:45 – 14:45 | Hall D

  • A KDIGO Session on State-of-the-Art Management of ADPKD
  • Organized by KDIGO, supported by Otsuka
  • 13:45 – 14:45 | Hall E

BI Med Livestream

personal information will not shared externally

AZ Livestream

personal information will not shared externally

Otsuka Livestream

personal information will not shared externally

Trevere Livestream

personal information will not shared externally